Better management results in patients typically needing fewer transfusions of donated blood components, preventing complications related to transfusions. The creation of patient blood management guidelines is being funded and overseen by the National Blood Authority. Patient blood management enhances patient outcomes by enhancing the patient's medical and surgical care in ways that support and conserve the patient's own blood.
Frequently Asked Questions
The market is segmented based on Segmentation, By Unit (Blood Components, Whole Blood), Articles (Instruments, Blood Processing Devices, Blood Transfusion Devices, Blood Culture Screening Devices, Diagnostic and Testing Instruments, Blood Storage Devices, Accessories, Syringes and Needles, Vials and Tubes, Blood Bank and Transfusion Software, Software, Assay Kits, Slide Staining, Blood Typing Reagents, Culture Media, Reagents and Kits, Blood Bags), End User (Hospitals, Blood Banks) – Industry Trends and Forecast to 2032
.
The Global Patient Blood Management Market size was valued at USD 15.12 USD Billion in 2024.
The Global Patient Blood Management Market is projected to grow at a CAGR of 7.8% during the forecast period of 2025 to 2032.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
